In short
- Minoxidil tablets carry a boxed warning: at blood pressure doses they can cause fluid around the heart and worsen angina. Taking them at low doses for hair loss is off-label.
- Topical minoxidil’s most common side effects are scalp itching and irritation. In 99 patch-tested allergy cases, minoxidil itself was the cause in 74.7% and propylene glycol in 17.1%.
- In a review of 1,404 people on low-dose oral minoxidil, 15.1% had unwanted hair growth, 1.7% lightheadedness, 1.3% fluid retention and 0.9% a fast heartbeat, with no life-threatening effects.
- At 5 mg a day in a 24-week trial of 90 men, 49% of the oral group grew unwanted body hair and 14% had headaches.
- The Rogaine labeling says shedding may increase for up to 2 weeks after you start, and that this is temporary.
- A label update approved Jan 14, 2026 warns that infants have grown excess hair after skin contact with a caregiver’s minoxidil-treated skin.
The most common side effects of topical minoxidil are itching and irritation of the scalp, and some people notice unwanted facial hair or a short burst of shedding when they start. Low-dose oral minoxidil, which is off-label for hair loss, more often causes unwanted body and facial hair, and less often lightheadedness, fluid retention and a fast heartbeat.
The two forms are the same drug, but they reach the body very differently: about 1.4% of a topical dose is absorbed through normal skin, while a tablet goes straight into the bloodstream. Here is what the labels and the studies report for each form, how often, and when to stop.
The boxed warning on minoxidil tablets
Minoxidil tablets are FDA-approved only for severe high blood pressure that has not responded to a diuretic and two other drugs. Their label opens with a boxed warning: minoxidil “may produce serious adverse effects,” including pericardial effusion (fluid around the heart), occasionally progressing to tamponade, and worsening angina.
At those blood pressure doses, the label reports:
- Pericardial effusion in about 3% of patients not on dialysis
- Temporary swelling (edema) in 7% of patients who had none at the start
- Thicker, darker body hair in about 80%, appearing within 3 to 6 weeks
Hair-loss doses are much lower, and using the tablets for hair loss is off-label. The foam and solution do not carry a boxed warning.
Side effects at a glance
| Side effect | Topical foam or solution | Low-dose oral minoxidil (off-label) |
|---|---|---|
| Scalp itching and irritation | Most common, per the label | Not applied to the scalp |
| Unwanted facial or body hair | Reported in women; the label calls it rare and reversible | 15.1% in a 1,404-patient review; 49% at 5 mg in a trial |
| Shedding when you start | May increase for up to 2 weeks, per the label | No label for hair loss |
| Lightheadedness or dizziness | On the label’s stop-use list | 1.7% in the review; 4.5% in a 310-patient study |
| Fluid retention or swelling | On the label’s stop-use list | 1.3% fluid retention in the review; 2.6% leg or arm swelling in the 310-patient study |
| Fast heartbeat | On the label’s stop-use list | 0.9% in the review |
| Headache | Not on the label | 0.4% in the review; 14% at 5 mg in a trial |
Topical minoxidil side effects
Itching, irritation and flaking
The Rogaine consumer booklets name itching and skin irritation of the treated scalp as the most common side effects. Strength matters: in a 48-week trial of 393 men, itching and local irritation were more frequent with the 5% solution than the 2%, and a 48-week trial of 381 women found the same, plus more unwanted hair growth.
Some reactions are a true allergy. A 2025 review of 99 patch-tested cases found that minoxidil itself was the allergen in 74.7% and propylene glycol, a solvent in the liquid, in 17.1%. That split matters: switching to the foam, which has no propylene glycol, helps only if the solvent is the cause. A second 2025 review advises patch testing for anyone with redness, scaling and itching, and offering people sensitive to propylene glycol a different formulation.
In a trial of 113 women, the 5% foam once a day caused significantly less local irritation, especially itching and dandruff, than the 2% liquid twice a day. Our liquid vs foam minoxidil guide compares the two in detail.
Unwanted hair growth
The men’s booklets say unwanted hair on the face and other parts of the body has been reported in women, and that it is rare and reversible; the women’s booklet says such reports have been infrequent. The women’s booklet gives three possible causes: the product spreading beyond the scalp, low levels absorbed into the blood, or an unrelated condition. In a 24-week trial of 404 women, the 5% foam once a day caused little scalp irritation or facial hair, with no clinically significant difference from the same foam without minoxidil.
Shedding when you start
The men’s labeling says hair loss “may increase temporarily for up to 2 weeks” after you begin, likely a sign that old hairs are making way for new ones. If it continues past 2 weeks, see a doctor. Our guide to how long minoxidil takes to work covers the timeline.
Hair color, texture and eyes
The Drug Facts label notes that some people see changes in hair color or texture. Both forms contain alcohol, which burns if it gets in your eyes; rinse with plenty of cool tap water.
Whole-body effects
The 48-week trials of the 2% and 5% liquids in 393 men and 381 women found no evidence of whole-body effects. The label still tells you to ask a doctor first if you have heart disease, and to stop and ask a doctor if you get chest pain, a rapid heartbeat, faintness or dizziness, sudden unexplained weight gain, or swollen hands or feet.
Children and pets
On Jan 14, 2026, the FDA approved a labeling update for Rogaine. It adds that excess hair growth has been reported in infants after skin contact with the application sites of caregivers using topical minoxidil, and that it reversed within months once the contact stopped. The labels now say to avoid contact between children and treated skin and to keep the product away from children and pets.
Oral minoxidil side effects
Low-dose oral minoxidil is off-label for hair loss. Three studies give the clearest numbers, at different doses and in different groups of people:
Scroll sideways to see the full table
| Side effect | 1,404-patient review (low doses, 2021) | 310-patient study (average 1.8 to 2.2 mg, 2025) | 90-man trial (5 mg, 2024) |
|---|---|---|---|
| Unwanted hair growth | 15.1% | 3.5% | 49% |
| Lightheadedness or dizziness | 1.7% | 4.5% | Not in the published summary |
| Fluid retention or swelling | 1.3% | 2.6% | Not in the published summary |
| Fast heartbeat | 0.9% | Not in the published summary | Not in the published summary |
| Headache | 0.4% | Not in the published summary | 14% |
| Stopped because of side effects | 1.7% | 22.2% to 28.9% of those with a side effect (the paper gives both figures) | Not in the published summary |
The 1,404-patient review saw no life-threatening effects, but it looked back at records and had no comparison group. In the 310-patient study, higher doses were linked to more dizziness, and the authors recommend starting low and increasing slowly.
Unwanted body and facial hair
This is the most common effect of the pill, and the one most closely tied to dose: 15.1% in the large review against 49% at 5 mg. The tablet label says it usually shows first on the temples, between the eyebrows and on the upper cheeks. After stopping, new growth stops, but it can take 1 to 6 months to look as it did before.
Fluid around the heart
Pericardial effusion is rare at hair-loss doses, but it has been reported. A 2022 case report described a healthy 40-year-old woman who developed leg and face swelling, then fluid around the heart and lungs, 3 weeks after starting 0.25 mg a day alongside other hair treatments; it cleared after she stopped. A second report described a young, healthy woman on 1.25 mg who developed fluid around the heart within weeks, with shortness of breath, chest pain, lightheadedness and leg swelling. Case reports show that something can happen, not how often.
Minoxidil side effects in women
Women face the same side effects, with a few differences:
- Facial hair. In the 381-woman trial, the 5% solution caused more unwanted hair growth than the 2%. The women’s products are a 5% foam once a day or a 2% solution twice a day; the men’s 5% solution is labeled not for women. The tablet label notes that hair growth is especially disturbing to women.
- More side effects on the pill. In the 310-patient study, women took a lower average dose than men (1.8 mg vs 2.2 mg a day) yet had more side effects overall, although the difference did not hold in a closer analysis. Two thirds of the 1,404-patient review were women.
- Pregnancy and breastfeeding. The topical labels say minoxidil may be harmful when pregnant or breastfeeding, and the tablet label says it should not be given to a nursing woman.
More on the choices for women is in minoxidil for women.
When to stop and call a clinician
The topical label says to stop and ask a doctor if any of these happen:
- Chest pain, a rapid heartbeat, faintness or dizziness
- Sudden, unexplained weight gain
- Swollen hands or feet
- Scalp irritation or redness
- Unwanted facial hair
- No regrowth after 4 months (6 months for the women’s foam)
On oral minoxidil, the same signs apply. Get urgent care for chest pain or shortness of breath, and tell your prescriber about new swelling or rapid weight gain.
Ways to lower the risk
- Use the labeled amount. The booklets say more frequent use or larger doses have not been shown to speed up growth and may increase side effects.
- Keep it on the scalp. Wash your hands after applying, and let the liquid dry for 2 to 4 hours before bed so it does not spread to your face or pillow.
- Keep treated skin away from babies and pets until it has dried, as the 2026 label update advises.
- Ask about patch testing if your scalp stays red or itchy; it tells you whether the problem is minoxidil or the solvent.
- For the pill, have a clinician check your blood pressure and heart history first, and ask about starting at a low dose.
The bottom line
Topical minoxidil’s side effects are mostly local: itching, irritation and, less often, unwanted facial hair, plus up to 2 weeks of extra shedding at the start. Low-dose oral minoxidil is off-label, its tablets carry a boxed warning, and its most common effect is unwanted body hair, with dizziness, swelling and a fast heartbeat in a small share of people.
Compare the two forms in oral vs topical minoxidil, and see our topical minoxidil and oral minoxidil pages, the cheapest oral minoxidil online, or providers on our hair loss hub.
Highest-scored hair loss providers
The three hair loss providers with our highest overall scores right now.
- Safety: Low-dose oral minoxidil carries a boxed warning for fluid around the heart and worsening angina. Read the safety information
- 01
Our top pick for October 2026
Happy HeadDermatologist-led care with the widest choice of pills and topicals
Rated 8.9 out of 10, Excellent
From $20/mo
Visit site for Happy Head (opens in a new tab) - 02MyDrHank
Finasteride or oral minoxidil with ongoing messaging
Rated 8.1 out of 10, Good
From $30/mo
Visit site for MyDrHank (opens in a new tab) - 03RxSpan MD
Compounded oral or topical blends with round-the-clock messaging
Rated 7.8 out of 10, Good
From $59/mo
Visit site for RxSpan MD (opens in a new tab)
Questions, answered
What are the most common side effects of minoxidil?
What are the side effects of oral minoxidil?
What are minoxidil side effects in women?
Can minoxidil affect your heart?
Do minoxidil side effects go away?
Sources
- Minoxidil tablets label with boxed warning, DailyMed (read Oct 27, 2026)
- Rogaine solution and foam labeling with consumer booklets, approved Jan 14, 2026 (FDA, read Oct 27, 2026)
- FDA approval letter for the Rogaine labeling update, Jan 14, 2026 (read Oct 27, 2026)
- Men’s Rogaine Extra Strength 5% solution Drug Facts, DailyMed (read Oct 27, 2026)
- Vañó-Galván et al., safety of low-dose oral minoxidil in 1,404 patients, J Am Acad Dermatol 2021
- Penha et al., oral vs topical minoxidil in 90 men, JAMA Dermatology 2024
- Ong et al., adverse effects of low-dose oral minoxidil in 310 patients, Skin Appendage Disord 2025
- Kiratiwongwan et al., allergic contact dermatitis to topical minoxidil, Dermatitis 2025
- Junge et al., contact dermatitis from topical minoxidil, Acta Derm Venereol 2025
- Olsen et al., 5% vs 2% topical minoxidil in 393 men, J Am Acad Dermatol 2002
- Lucky et al., 5% and 2% minoxidil solutions in 381 women, J Am Acad Dermatol 2004
- Blume-Peytavi et al., 5% foam vs 2% solution in 113 women, J Am Acad Dermatol 2011
- Bergfeld et al., 5% minoxidil foam vs vehicle in 404 women, J Drugs Dermatol 2016
- Gupta et al., Minoxidil: a comprehensive review, J Dermatolog Treat 2022
- Dlova et al., pericardial and pleural effusion on low-dose oral minoxidil, JAAD Case Reports 2022
- Trüeb et al., serious complication of low-dose oral minoxidil, JAAD Case Reports 2022